Bone Growth Stimulator Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Bone Growth Stimulator Market Analysis
The bone growth stimulator market was valued at approximately USD 985 million in 2020 and is expected to witness a revenue of USD 1,425 million in 2026, with a CAGR of 5.9% over the forecast period.
The impact of COVID-19 on the studied market is expected to be significant. On one hand, due to the lockdown and travel restriction imposed to combat the transmission of the COVID-19 virus, incidences of road accidents and consequent fractures and injuries have reduced, which has highly impacted the studied market. On the other hand, as per a research article published in the Journal of Clinical Pharmacy and Therapeutics, 2020, the elderly population became more prone to bone fractures during the pandemic due to lack of out-of-home activities, sedentary lifestyle, and decreased exposure to sunlight and consequent Vitamin D deficiency. Additionally, as per a research study published in Bone and Joint Open, 2020, there was a significant increase in hip fractures, especially among the elderly population in the United Kingdom, during the pandemic, which was majorly attributed to the lack of caretakers and relatives to take care of the aged people. Thus, the increasing incidence of fractures and trauma cases among the elderly population during the pandemic turns the spotlight on the bone growth stimulators, in turn driving the growth of the studied market.
The bone growth stimulator market is majorly driven by factors such as the rising incidence of bone and joint disorders, growing demand for non-invasive and minimally invasive surgeries across the world, and the growing geriatrics population.
Osteoarthritis is considered to be one of the most prevalent articular diseases among the population above the age of 65 years. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have been diagnosed with arthritis, and this number is estimated to reach 78 million by 2040. Additionally, as per World Population Prospects: The 2019 Revision Data, in 2019, 1 in 11 people was above the age of 65 years. This number is expected to increase to 1 in 6 people by 2050.
An increasing incidence of trauma and accident cases worldwide is considered as one of the major factors likely to boost the demand for the studied market. According to the National Safety Council, in 2018, around 4.5 million people were severely injured due to accidents. Thus, given the aforementioned factors, the bone growth stimulator market is expected to witness significant growth over the forecast period globally.
Bone Growth Stimulator Market Trends
This section covers the major market trends shaping the Bone Growth Stimulator Market according to our research experts:
The External Bone Growth Stimulator Segment is Expected to Register Good Growth Over the Forecast Period
The external bone growth stimulators are expected to witness a significant market share over the forecast period. The advanced features of external bone growth stimulators, namely their light weight, ease of handling, and portability, act as a major driver for the growth of the current segment.
According to the research study published in Bone and Joint Open, 2020, in 2020, there was an increase in fractures and minor injuries requiring surgery among elderly patients during the COVID-19 lockdown in the United Kingdom, as compared to 2019. Though there was an increase in minor injuries requiring minor surgeries, the numbers of polytrauma and open fractures were reduced during the COVID-19 era due to a reduction in road traffic and in participation in outdoor sports activities. Thus, COVID-19 is expected to impact the studied market significantly during the pandemic era.
The demand for these products is increasing due to the rising number of bone fracture cases and the effectiveness of the external bone growth stimulators in healing fractures. According to a research article published in the Archives of Osteoporosis, 2020, fragility fractures in the largest five countries of the European Union plus Sweden (EU6) accounted for 2.7 million in 2017, and is expected to reach 3.3 million in 2030, which is a 23% increase from 2017. Additionally, as per the research study published in the Orthopedic Trauma Association International, 2020,14% of the Australian population have osteoporosis and 60,000 hip fractures have been estimated to occur by 2050 in Australia. This indicates the rising burden of fracture across the world. Therefore, there is a growing demand for external bone growth stimulators, which will contribute to the growth of the market for the same over the forecast period.
North America Hold the Major Share in the Studied Market and is Expected to Dominate Over the Forecast Period.
North America holds the largest share of the bone growth stimulator market. This is majorly attributed to the increasing geriatric population and the growing burden of orthopedic diseases in the region. According to the National Spinal Cord Injury Statistical Center's Spinal Cord Injury, Facts and Statistics, 17,730 new Spinal Cord Injury cases occur each year and nearly 249,000 to 363,000 people are living with Spinal Cord Injury in the United States in 2019. Also, according to the Population Reference Bureau's Population Bulletin's Aging in the United States, the Americans aged 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. The rising elderly population is more prone to bone fractures and thus drives the growth of the studied market.
According to the research article published in Arthroscopy, Sports Medicine and Rehabilitation, 2020, Northwell Health mandated the cancellation of all elective surgical cases to reserve the resource in the treatment of COVID-19 patients, and only emergency orthopedic procedures were performed. Northwell health performed approximately 2,970 emergency orthopedic surgeries during a 4-week period at its 16 orthopedic hospital sites in the United States during the COVID-19 pandemic. Hence, COVID-19 is expected to impact the studied market growth moderately.
Additionally, the increasing product approvals in the region and the existence of major players in the United States surge the market growth. For instance, in Feb 2020, Orthofix received FDA approval for its updated version of its bone growth stimulator app, STIM onTrack. Thus, the Bone Growth Stimulator Market is expected to witness huge growth over the forecast period in North America.
Bone Growth Stimulator Industry Overview
The bone growth stimulators market is highly consolidated and consists majorly of global players. With the rising burden of orthopedic diseases and technological advancements, few small to mid-sized companies are also penetrating the market. The key players of the studied market include Medtronic plc, Johnson and Johnson (Depuy Synthes), Bioventus LLC, Orthofix International N.V., Zimmer Biomet, and Stryker Corporation, among others. Also, expansion strategies of the global players are proving to be beneficial for the emerging market as product availability is increasing.
Bone Growth Stimulator Market Leaders
-
Medtronic Plc
-
Zimmer Biomet
-
Orthofix International NV
-
Johnson and Johnson (DePuy Synthes)
-
Bioventus LLC
*Disclaimer: Major Players sorted in no particular order
Bone Growth Stimulator Market News
In February 2020, Orthofix Medical Inc. received US FDA approval for its STIM on Track, mobile app version 2.1 to advance the treatment with its bone growth stimulators such as CervicalStim, SpinalStim, and PhysioStim.
In January 2020, Medtronic acquired Stimgenics to expand its portfolio in the Differential Target Multiplexed Spinal Cord Stimulation Therapy.
Bone Growth Stimulator Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Bone and Joint Disorders
4.2.2 Growing Demand for the Non-Invasive or Minimally Invasive Surgeries
4.2.3 Development of Biocompatible Synthetic Bone Grafts
4.3 Market Restraints
4.3.1 High Cost of Surgeries and Limited Medical Reimbursements for Bone Growth Stimulation Products
4.3.2 Adverse Effects of BMP-Based Treatment
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Bone Growth Stimulation Devices
5.1.1.1 External Bone Growth Stimulators
5.1.1.1.1 Combined Magnetic Field (CMF) Devices
5.1.1.1.2 Capacitive Coupling (CC) Devices
5.1.1.1.3 Pulsed Electromagnetic Field (PEMF) Devices
5.1.1.2 Implanted Bone Growth Stimulators
5.1.1.3 Ultrasonic Bone Growth Stimulators
5.1.2 Bone Morphogenetic Proteins (BMP)
5.1.3 Platelet-Rich Plasma (PRP)
5.2 By Application
5.2.1 Spinal Fusion Surgeries
5.2.2 Delayed Union & Non-union Bone Fractures
5.2.3 Oral and Maxillofacial Surgeries
5.2.4 Other Applications
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Home Care
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Arthrex, Inc.
6.1.2 Bioventus LLC
6.1.3 Johnson and Johsnon (Depuy Synthes)
6.1.4 Medtronic Plc
6.1.5 Orthofix International N.V
6.1.6 Smith & Nephew Plc
6.1.7 Stryker Corporation
6.1.8 Zimmer Biomet
6.1.9 DJO Finance, LLC
6.1.10 Isto Biologics
6.1.11 Ossatec Benelux B.V.
6.1.12 Altis Biologics Pty Ltd
6.1.13 ITO Co., Ltd
6.1.14 Terumo BCT, Inc.
6.1.15 Wright Medical Group N.V.
6.1.16 Elizur Corporation
6.1.17 IGEA SpA
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Bone Growth Stimulator Industry Segmentation
A bone growth stimulator is a device that stimulates the natural healing of bones by sending lowlevel pulses of electromagnetic energy to the injury or fusion site. A bone growth stimulator is beneficial after a multi-level fusion procedure or for patients who have certain comorbidities, such as smoking addiction or diabetes. The bone growth stimulator market is segmented by product, application, end user, and geography. By product, the market is segmented into bone growth stimulation devices, bone morphogenetic proteins (BMP), and platelet-rich plasma (PRP). By application, the market is segmented into spinal fusion surgeries, delayed union and non-union bone fractures, oral and maxillofacial surgeries, and other applications. By end user, the market is segmented into hospitals and clinics, home care, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | |||||||||
| |||||||||
| Bone Morphogenetic Proteins (BMP) | |||||||||
| Platelet-Rich Plasma (PRP) |
| By Application | |
| Spinal Fusion Surgeries | |
| Delayed Union & Non-union Bone Fractures | |
| Oral and Maxillofacial Surgeries | |
| Other Applications |
| By End User | |
| Hospitals and Clinics | |
| Home Care | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Bone Growth Stimulator Market Research FAQs
What is the current Global Bone Growth Stimulator Market size?
The Global Bone Growth Stimulator Market is projected to register a CAGR of 5.90% during the forecast period (2024-2029)
Who are the key players in Global Bone Growth Stimulator Market?
Medtronic Plc, Zimmer Biomet, Orthofix International NV, Johnson and Johnson (DePuy Synthes) and Bioventus LLC are the major companies operating in the Global Bone Growth Stimulator Market.
Which is the fastest growing region in Global Bone Growth Stimulator Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Bone Growth Stimulator Market?
In 2024, the North America accounts for the largest market share in Global Bone Growth Stimulator Market.
What years does this Global Bone Growth Stimulator Market cover?
The report covers the Global Bone Growth Stimulator Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Bone Growth Stimulator Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
What are the emerging trends in Bone Growth Stimulation technology?
The emerging trends in Bone Growth Stimulation technology are a) Advancements in miniaturization b) Personalization c) Combination therapies
Bone Growth Stimulator Industry Report
The bone growth stimulators market is poised for robust growth due to increasing bone and joint disorders, an aging population, and a spike in minimally invasive procedures. These devices not only speed up bone healing and reduce hospital stays but also bring down medical costs due to lower infection risks, making them especially valuable in treating conditions like osteoarthritis. Innovations such as high-frequency sound wave integration in stimulators are opening new avenues for market expansion. Alongside technological advances, there's a shift toward preventive maintenance and IoT-enabled monitoring, streamlining operations and minimizing downtime. Key regions like North America lead due to extensive healthcare facilities, while the Asia Pacific is rapidly growing fueled by investments in healthcare infrastructure. With ongoing product development and a rising emphasis on less invasive medical treatments, the market is set to continue its upward trajectory. For detailed market insights and a forecast outlook, including a historical overview, a free sample report is available from industry analyses by Mordor Intelligence™.
